Home › Gilead's India Patent Snag May Spur Low-Cost Sovaldi Copies
 

Keywords :   


Gilead's India Patent Snag May Spur Low-Cost Sovaldi Copies

2015-01-16 02:44:37| Biotech - Topix.net

The Indian patent office's rejection of a key patent for Gilead Sciences' Hepatitis C treatment Sovaldi may pave the way for more low-cost copies in the country. The New Delhi patent office this week rejected one of the patents for Sovaldi on the grounds that it "lacks novelty" and lacks an inventive step.

Tags: india copies patent spur

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
27.09Summary for Remnants of John (EP5/EP102024)
27.09Tropical Storm Joyce Graphics
More »